,37 Sodhi et al.38reported that GLP1-RAs were associated with increased risks of bowel obstruction (HR: 4.22, 95% CI: 1.02-17.4) compared to bupropion-naltrexone in patients with obesity. The gene discussed is GLP1R; the disease is intestinal obstruction.